During the past decade, Pharmaron CPC, Inc. conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 1 clinical trials were completed. i.e. 3.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharmaron CPC, Inc." #1 sponsor was "Luye Pharma Group Ltd." with 3 trials, followed by "Biogen" with 2 trials sponsored, "Entasis Therapeutics" with 2 trials sponsored, "Neurop Inc." with 2 trials sponsored and "PATH" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmaron CPC, Inc." #1 collaborator was "Pharmaron" with 3 trials as a collaborator, "Denali Therapeutics Inc." with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Centers for Disease Control and Prevention" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Pharmaron CPC, Inc." are "Healthy" (9 trials), "Healthy Volunteers" (4 trials), "Acinetobacter Baumannii-calcoaceticus Complex Infections" (2 trials), "Healthy Adult Subjects" (2 trials) and "Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Pharmaron CPC, Inc." in a lesser frequency.

Most popular intervention types in "Pharmaron CPC, Inc." are "Drug" (30 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "ETX2514" (2 trials), "LY03005" (2 trials), "NP10679" (2 trials) and "[14C] BIIB122 ([14C] DNL151)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pharmaron CPC, Inc." are 27 trials for "All" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Pharmaron CPC, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Pharmaron CPC, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pharmaron CPC, Inc., 30 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".